Overview

Update
Acquisitions
1 Acquisition
IPO / Stock
Went Public on Oct 10, 2013 / NASDAQ:MGNX
Headquarters:
Rockville, MD
Description:
MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.
Founders:
Categories:
Health Care, Biotechnology, Manufacturing
Website:
http://www.macrogenics.com
Social:

Company Details

Update

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.

The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology.

The company was founded in 2000 and is headquartered in Rockville, Maryland.

Funding Rounds (2) - $57.02M

Update
DateAmount / RoundValuationLead InvestorInvestors
Jan, 2011$12.02M / Private Equity0
May, 2006$45M / Series C10

Acquisitions (1)

Update
DateAcquiredAmount
Jul 17, 2008Unknown

Current Team (10)

Update

Competitors (1)

Update
  • LigoCyte Pharmaceuticals is focused on developing vaccines and monoclonal antibodies for gastrointestinal and respiratory indications.

Offices/Locations (1)

Update
  • Headquarters

    1500 East Gude Drive

    Rockville, MD 20850

    USA

Past Team (5)

Update

Images (1)

Update

Add Products

Add Sub Organizations

Add Memberships

Add Customers

Add Partners

Add Videos